The genetic disorder cystic fibrosis, which affects approximately 80,000 individuals in Europe and North America, is caused by mutations in the CFTR gene [1] [2] [3] . Chronic microbial lung infections, most commonly caused by the opportunistic bacterial pathogen P. aeruginosa, lower the life expectancy of people with cystic fibrosis owing to excessive lung tissue remodeling and destruction 4 . How mutation or absence of CFTR, which is primarily expressed in ciliated and submucosal gland epithelial cells of the respiratory tract 5, 6 , promotes pulmonary infections, is still incompletely understood. Several studies support the notion that cystic fibrosis cells and respiratory tissues have a proinflammatory status, which may facilitate bacterial lung colonization and infection [7] [8] [9] [10] .
Here we investigated the role of sphingolipids in the pathogenesis of cystic fibrosis. CFTR belongs to the ATP-binding cassette transporter family, which has been previously shown to be involved in lipid transport 11, 12 . Furthermore, studies indicate that defective CFTR leads to higher pH levels in intracellular organelles 13, 14 , which might be important for the regulation of the cellular sphingolipid metabolism by enzymes with activity peaks at acidic pH values. Because sphingolipids are crucially involved in the regulation of cell survival 15, 16 , nuclear factor-kB activation 17 and expression of proinflammatory cytokines 18 , we hypothesized that alteration of sphingolipid metabolism due to alterations in intracellular pH may have a key role in the pathogenesis of cystic fibrosis lung disease.
We show that deficiency of Cftr results in an accumulation of cellular ceramide in the respiratory tract of uninfected Cftr-deficient mice. The accumulation is caused by the alkalinization of Cftrdeficient vesicles in respiratory cells leading to an imbalance of the activities of Asm and acid ceramidase. A similar accumulation of ceramide was detected in respiratory epithelial cells and airways of subjects with cystic fibrosis. Normalization of pulmonary ceramide prevented chronic pulmonary inflammation, impairment of mucociliary clearance and high susceptibility to severe pulmonary P. aeruginosa infections in Cftr-deficient mice.
RESULTS

Cftr deficiency and ceramide accumulation
To test the hypothesis that deficiency of functional Cftr results in alterations of the sphingolipid metabolism in the respiratory tract, we determined the concentration of ceramide in the lungs of the mouse strains Cftr tm1Unc -Tg (FABPCFTR) (abbreviated Cftr KO ) and B6.129P2(CF/3)-Cftr TgH(neoim)Hgu (abbreviated Cftr MHH , syngenic to C57BL/6) and in the appropriate wild-type strains. The mutant mice lack functional Cftr in the respiratory tract (collectively named Cftrdeficient mice). Our results show a significant increase of ceramide in the lungs of Cftr-deficient mice compared to controls (Fig. 1a) . Notably, this increase was age-dependent, whereas ceramide levels did not differ with age in the wild-type mice.
To identify cells accumulating ceramide in Cftr KO and Cftr MHH mice, we stained isolated bronchial epithelial cells with two different monoclonal antibodies to ceramide. Excessive ceramide accumulation was observed in ciliated respiratory cells of Cftr-deficient mice, but not wild-type mice (Fig. 1b) . To further locate ceramide-overexpressing cells, we stained paraffin sections of lungs from wild-type, Cftr KO and Cftr MHH mice for ceramide. Ceramide accumulation was observed in the respiratory tract epithelium and submucosa of Cftr-deficient mice (Fig. 1c) . Control stainings with irrelevant Cy3-coupled antibodies were negative (data not shown). Alveolar epithelial cells, which constitute the majority of cells in the lung, did not contain substantial amounts of ceramide, either in wild-type or in Cftr KO or Cftr MHH mice (Fig. 1c) . Concurrently with the presence of Cftr in macrophages 14 , we detected a sixfold increase in ceramide in mouse lung macrophages obtained by pulmonary lavage (data not shown).
To address the topology of ceramide in respiratory epithelial cells, we performed confocal microscopy. These studies indicated a marked accumulation of ceramide-containing vesicles in the respiratory epithelial cells of Cftr-deficient mice, and also the accumulation of ceramide in other cell membranes (Fig. 1d) . Fluorescence activated cell sorting (FACS) data confirmed the accumulation of ceramidecontaining vesicles in lung extracts from Cftr-deficient mice (Fig. 1e) , as indicated by the increased percentage of ceramide-positive vesicles. In addition, we detected an increase in the absolute ceramide amount in these vesicles, as indicated by the increased Cy3 signal measuring binding of the Cy3-labeled antibodies to ceramide in the FACS studies (Fig. 1e) . The FACS data showed that the accumulation of ceramidecontaining lysosomes had already occurred in young, 12-week-old Cftr-deficient mice, but to a lower degree than in older mice. Analysis of samples from Cftr KO revealed the same results (data not shown).
To further support the hypothesis that ceramide accumulates in Cftr-deficient cells and to localize where this accumulation would occur, we performed immunogold electron microscopy on lung sections from wild-type and Cftr-deficient mice. Ceramide predominantly located to intracellular vesicles in Cftr-deficient respiratory epithelial cells versus normal control cells (Fig. 1f) . The accumulation of ceramide was not restricted to cathepsin D-positive lysosomes, but was also observed in other vesicles.
To test whether these findings in mouse models of cystic fibrosis are also relevant for people with cystic fibrosis, we isolated nasal respiratory epithelial cells from adult individuals with cystic fibrosis and healthy individuals and stained the cells for ceramide. Additionally, lung transplant material from three people with cystic fibrosis and lung material from three normal donors was stained. The results showed an accumulation of ceramide in the membrane of nasal epithelial cells (Fig. 1g) , respiratory epithelial cells and submucosal glands (Fig. 1h) from 17 healthy individuals and 18 individuals with cystic fibrosis revealed a 4 ± 0.4-fold increase in the ceramide signal in cells from subjects with cystic fibrosis (P o 0.01, t-test).
Defective acidification and ceramide accumulation
Recent studies have shown that CFTR deficiency in alveolar macrophages results in a lysosomal pH shift from pH 4.5 to at least pH 5.9 (ref. 14) . Other studies have shown that an increase in pH to 5.9 reduces Asm activity by only B35%, whereas the activity of acid ceramidase is reduced by more than 90% at this pH. In some respects, these results mimic Farber's disease, which is caused by a deficiency of acid ceramidase and results in an accumulation of ceramide 19, 20 . Furthermore, at a pH of 5.9, acid ceramidase shows a reverse activity-producing ceramide instead of consuming it 19 . The imbalance of Asm and acid ceramidase and the reverse activity of acid ceramidase at a vesicular pH of 5.9 should result in a net accumulation of ceramide in an in vivo situation.
To investigate this hypothesis, we determined the pH in cellular vesicles of respiratory epithelial cells from wild-type and 24-week-old Cftr-deficient mice. Measurements of the vesicular pH in Cftr-deficient respiratory epithelial cells employing lysosensor-green revealed an increase in the pH in these vesicles to a value of 5.9 ( Fig. 2a) . This increase was mimicked by adding the Cftr inhibitor CFTR inh -172 to wild-type cells (Fig. 2a) .
Next, we confirmed the pH dependency of Asm and acid ceramidase activity in mouse lung preparations, as well as the reverse activity of acid ceramidase at pH 4.5, 5.0 and pH 5.9. The data showed an almost complete inhibition of acid ceramidase at pH 5.9 ( Fig. 2b) . In fact, at this pH, the enzyme showed the anticipated reverse activity, producing ceramide (Fig. 2b) . In contrast, the activity of Asm was reduced by only 35% at pH 5.9 (Fig. 2b) .
To show that inhibition of acid ceramidase results in cellular ceramide accumulation, we inhibited the acid ceramidase in respiratory epithelial cells of wild-type mice in vivo by treating them with N-oleoylethanolamine administered by inhalation. Alternatively, intracellular vesicles were directly alkalinized by inhalation of bafilomycin, nigericin, chloroquin or NH 4 Cl. The results confirmed that both direct inhibition of acid ceramidase or alkalinization of lysosomes increases the concentration of ceramide in wild-type respiratory cells (Fig. 2c) .
To directly show that lysosomal pH is key for the accumulation of ceramide in Cftr-deficient cells, we acidified isolated vesicles from Cftr-deficient lung cells in vitro. In FACS studies of isolated vesicles from Cftr-deficient lung cells that were either left at a pH of 5.9 or acidified to pH 4.5 ( Fig. 2d) 
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+/- Cy3-coupled antibodies served to measure the amount of ceramide in a single vesicle. The data showed that acidification of vesicles isolated from Cftr-deficient cells reduced the vesicular ceramide abundance (Fig. 2d) . In contrast, alkalinization of vesicles isolated from wild-type cells from pH 4.5 to pH 5.9 resulted in ceramide accumulation (Fig. 2d) . Previous studies have shown that Cftr also functions as a direct transmembrane transporter or as a regulator of the transmembrane transport of sphingosine-1-phosphate 12 . However, we did not detect a significant increase in sphingosine-1-phosphate abundance in Cftrdeficient mice. Sphingosine was increased in the lungs of Cftr-deficient mice, but the total sphingosine amounts were 0.05% of those of ceramide, suggesting that a defect in the uptake of sphingosine-1-phosphate via Cftr may not be the major cause for ceramide accumulation in Cftr-deficient cells (further details in Supplementary Note 1 online).
Inhibition of Asm normalizes ceramide
Ceramide is generated in cellular membranes from sphingomyelin by the constitutive activity of Asm or by de novo synthesis [21] [22] [23] . The data described above indicate that the accumulation of ceramide within the lungs of Cftr-deficient mice is caused by an imbalance between Asm and acid ceramidase activities. Thus, Asm might be a potential pharmacological target to manipulate the sphingolipid metabolism in Cftr-deficient mice. We therefore tested whether inhibition of Asm normalizes the increased ceramide concentration in the respiratory tracts of Cftr KO and Cftr MHH mice. Partial inhibition of Asm was achieved either by intraperitoneal injection of amitriptyline (10 mg/kg twice daily for 2.5 d), which induces a proteolytic degradation of Asm 24 , or instead by crossing Cftr KO mice with Asm knockout mice (Smpd1 -/-) to obtain mice absent in Cftr expression and partially deficient for Asm (Cftr KO Smpd1 +/-; Fig. 2e ). Biochemical assays and immunofluorescence studies on respiratory epithelial cells from Cftr KO , Cftr MHH and Cftr KO Smpd1 +/-mice revealed that either amitriptyline-mediated degradation or genetic heterozygosity of Asm almost normalized pulmonary ceramide levels in these mice (Fig. 2f,g ).
Amitriptyline has been recently shown to result in the degradation of acid ceramidase in addition to that of Asm 25 . Our data indicated that amitriptyline not only reduced the already very low acid ceramidase activity at pH 5.9, but also the ceramide-producing reverse activity of the acid ceramidase at this pH (Fig. 2e) . Thus, inhibition of ceramide generation via Asm and acid ceramidase was the predominant effect of amitriptyline at pH 5.9, resulting in a net reduction in cellular ceramide. Because the specific activity of Asm is approximately 40-fold higher than the reverse activity of acid ceramidase and 250-fold higher than the ceramide-consuming activity of acid ceramidase at a pH of 5.9, we assumed that Asm is the primary target of amitriptyline. This is also consistent with the observation that the heterozygosity of the gene encoding Asm, which does not affect acid ceramidase expression, also lowered ceramide levels in the lungs of Cftr-deficient mice.
Normalization of ceramide prevents P. aeruginosa infection
To test the implications of these findings for bacterial lung infections in cystic fibrosis, we determined the susceptibility of wild-type, Cftr KO and Cftr MHH mice to pulmonary P. aeruginosa infection. Increased susceptibility of Cftr-deficient mice to P. aeruginosa lung infection has been reported previously 26, 27 . Whereas wild-type mouse lungs contained only B1 Â 10 3 colony-forming units (CFU) of P. aeruginosa per 100 mg of homogenized lung tissue 2 h after inoculation, Cftr KO and Cftr MHH mice were significantly more susceptible to infection, with B1 Â 10 6 CFU of P. aeruginosa strain 762 per 100 mg lung tissue (Fig. 3a) . Pharmacological or genetic inhibition of Asm protected Cftr KO and Cftr MHH mice from pulmonary P. aeruginosa infections. Amitriptyline-treated Cftr KO or Cftr MHH mice or the Cftr KO Smpd1 +/-mice, had substantially fewer P. aeruginosa CFU in the lung than the respective Cftr-deficient mouse strains 2 h after intranasal inoculation with 1 Â 10 8 CFU of P. aeruginosa 762 (Fig. 3a) . Similar data were obtained after infection of Cftr KO or Cftr MHH mice with P. aeruginosa strains 769 and American Type Culture Collection 14115 (Fig. 3b) . The susceptibility of Cftr KO and Cftr MHH mice to pulmonary P. aeruginosa infection increased with the age of the mice (Fig. 3a) , corresponding to the age-dependent increase in pulmonary ceramide concentration. A slightly increased susceptibility to bacterial infection was already detectable in mice with cystic fibrosis at ages of 8 and 12 weeks (Fig. 3a) , although the susceptibility of younger mice was much lower than it was in mice at 16 and 24 weeks of age (Fig. 3a) , which is consistent with the lower accumulation of ceramide in Cftr-deficient young mouse lungs. Control experiments revealed that when mice were intranasally challenged with 1 Â 10 8 CFU of P. aeruginosa, almost all bacteria could be recovered from the noses of the mice 2 min after application, whereas the lungs were still free of pathogens (Fig. 3c) . There was no difference in recovered CFU between wild-type and Cftr-deficient mice at this early time point. In the early phase, that is, 15, 30 and 60 min after infection, P. aeruginosa migrated to the lower airways and bacterial numbers increased in the lungs of all mice to a similar degree (Fig. 3c) . After approximately 60 min, wild-type mice started to eliminate the bacteria, whereas in Cftr-deficient mice, bacteria started to grow exponentially (Fig. 3c) . Infection of the mice with only 1 Â 10 7 CFU resulted in appropriately lower absolute numbers of bacteria in the lung 2 h after the infection, showing a marked difference in the number of CFU between wild-type and Cftr-deficient mice similar to that observed with the higher infectious dose (Fig. 3c) .
We also challenged the lungs of Cftr-deficient and wild-type mice with Streptococcus pneumoniae, a pathogen that rarely infects people with cystic fibrosis. The data revealed no difference between the pulmonary infection of wild-type and Cftr-deficient mice with S. pneumoniae (data not shown).
Next, we explored the relationship between P. aeruginosa lung colonization rates and mouse mortality. Our analysis of the 7-d survival rates indicated that initially high P. aeruginosa CFU correlated with mortality that was significantly reduced (P o 0.05) by pharmacological inhibition or genetic heterozygosity of Asm (Fig. 3d) .
Accumulated ceramide causes inflammation
Next, we aimed to identify mechanisms by which accumulated ceramide mediates the hypersusceptibility of Cftr-deficient mice to Age (weeks) 16 P. aeruginosa infection. To this end, we tested typical immunological changes in the respiratory tract that are known to increase the susceptibility to P. aeruginosa and/or have been shown to be altered in cystic fibrosis-affected cells or lung tissues [7] [8] [9] [10] . Cftr KO and Cftr MHH mice showed a constitutive increase in expression of interleukin-1 (IL-1) and keratinocyte-derived chemokine (KC), the mouse homolog of human IL-8, in their lungs (Fig. 4a) . Genetic or pharmacological inhibition of Asm normalized the levels of pulmonary IL-1 and KC in Cftr-deficient mice (Fig. 4a) , suggesting that cytokine upregulation is linked to ceramide accumulation in Cftr-deficient mice. Of note, the mice, held in a pathogen-free environment, were free of any infection, as determined by repeated microbial cultures of lung homogenates and serological testing for multiple microbial species, thus ruling out changes in these cytokine levels due to an unrelated microbial infection.
In addition to the age-dependent increases in ceramide, IL-1 and KC expression, lung tissues of Cftr-deficient mice showed an agedependent increase in macrophage and neutrophil cell numbers that was corrected by genetic or pharmacological inhibition of Asm (Fig. 4b,c) . Compared to wild-type mice, untreated Cftr KO and Cftr MHH mice showed increased macrophage (Fig. 4b) and neutrophil (Fig. 4c) cell counts in the lungs at ages of 30 and 52 weeks. The high macrophage and neutrophil cell numbers were almost normal in Cftr KO Smpd1 +/-mice and after treatment of Cftr KO mice with amitriptyline (Fig. 4b,c) . In Cftr KO mice, macrophages clustered around mouse submucosal glands (Fig. 4d) , the principal sites of CFTR expression in humans 6 . Macrophages (Fig. 4e) and neutrophils (Fig. 4f) were also present in high numbers in the bronchial-associated lymphatic tissue, whereas only marginal numbers of macrophages and neutrophils were present in the lungs of wild-type mice.
Accumulated ceramide, cell death and deposition of DNA Aside from its impact on cytokine expression and inflammatory cell recruitment, ceramide has previously been shown to be essential in the induction of cell death 15, 16 . Therefore, we tested whether Cftr-deficient mice have an increased death rate of respiratory epithelial cells and whether this contributes to the hypersusceptibility of Cftr-deficient mice to P. aeruginosa infection.
TUNEL staining of lung sections of Cftr KO or Cftr MHH mice revealed a larger number of dead cells dispersed within the respiratory mucosa of large and medium-sized bronchi when compared to wild-type mice, in whom cell death was rarely observed (Fig. 5a,b) . The rate of respiratory epithelial cell death increased in Cftr-deficient mice in an age-dependent manner, starting with a few dead cells in the respiratory tract in 12-week-old mice (Fig. 5b) . The increased death rate of respiratory epithelial cells in Cftr KO and Cftr MHH mice was returned to normal by pharmacological or genetic inhibition of Asm (Fig. 5a,b) or application of the broad-spectrum caspase inhibitor Z-VAD, which has been previously shown to block apoptosis in vivo 28 (Fig. 5a,b) .
Next, we investigated whether increased cell death, caused by the accumulation of ceramide in nasal and bronchial epithelial cells, results in DNA deposits on the respiratory epithelium. DNA deposits were detectable on the mucosal lung surface in 12-17% of bronchi in Cftr KO and Cftr MHH mice (Fig. 5c,d ), compared to a maximum of 2% of bronchi in wild-type mice. Young, 12-week-old mice showed a small, but distinct increase in DNA deposits in bronchi (Fig. 5d) . To test whether the increased cell death rate in Cftr-deficient mice is linked to deposition of DNA in the airways of these mice, we treated Cftr KO and Cftr MHH mice with Z-VAD. Z-VAD inhibited the formation of DNA deposits within the airway mucus in Cftr-deficient mice (Fig. 5c,d) . Notably, pharmacological inhibition of Asm by amitriptyline, genetic heterozygosity of Smpd1 or inhalation of recombinant DNase also abrogated DNA deposition on the mucosal lung surface (Fig. 5c,d ).
DNA deposits and P. aeruginosa adhesion and infection
To investigate whether DNA deposits on the respiratory epithelium of Cftr-deficient mice mediate adherence of P. aeruginosa, we incubated the respiratory cell line A549 with 10 mg denatured salmon sperm DNA, which led to an increased adherence of P. aeruginosa along DNA fibers (Fig. 6a) , indicating the importance of DNA for bacterial adhesion. Therefore, we treated both Cftr KO and Cftr MHH mice with either recombinant human DNase or Z-VAD before bacterial challenge. Both recombinant human DNase treatment and Z-VAD treatment effectively lowered P. aeruginosa cell numbers in the lungs of Cftr KO or Cftr MHH mice (Fig. 6b) , suggesting that DNA deposits derived from dead epithelial cells facilitate P. aeruginosa adhesion and infection. Neither recombinant human DNase nor Z-VAD changed pulmonary ceramide abundance (data not shown).
A diet reduces ceramide in Cftr-deficient mice A recent study 29 shows a decrease in ceramide in the lungs of Cftrknockout mice compared to their littermate controls, which seems to be inconsistent with our data. However, these studies used mice that are completely deficient for Cftr. Mice completely lacking Cftr in the intestine usually die after birth, owing to intestinal obstruction, and therefore require a special liquid diet such as Peptamen 29 . We tested this diet and observed that it reduced ceramide levels and inhibited Asm by inducing a B300% increase of cholesterol in the lungs of Cftrdeficient mice ( Supplementary Fig. 1a-d online) , effects that are consistent with the previously published interference of cholesterol with Asm activity 30 and that were prevented by treatment with simvastatin 31 .
DISCUSSION
In the present study we demonstrate an age-dependent hypersusceptibility of Cftr-deficient mice to P. aeruginosa infection that is caused by increased cellular ceramide abundance in the lungs of Cftr-deficient mice. Inhibition of Asm, acid ceramidase or both by treatment of Cftr KO or Cftr MHH mice with amitriptyline or by generation of Cftr KO Smpd1 +/-mice normalized pulmonary ceramide levels, prevented pulmonary P. aeruginosa infections and increased survival of infected mice.
According to current models, sphingomyelin is constitutively metabolized to ceramide by Asm and further degraded to sphingosine by acid ceramidase 32 . This process is thought to be located predominantly in lysosomes but also in other membranes such as the plasma membrane. Our data indicate that acidification of intracellular vesicles mediated by Cftr, presumably through the provision of counter ions to permit higher lumenal H + concentrations 14, 33, 34 , is crucial for the concerted regulation of ceramide by the activities of Asm and acid ceramidase. The alkalinization of Cftr-deficient vesicles in respiratory cells of Cftr-deficient mice to a pH of 5.9 results in an imbalance of the Asm and acid ceramidase activities, with a reduced consumption of ceramide and, finally, a net accumulation of ceramide. Our FACS and confocal and electron microscopy studies indicate an increase in the number of ceramide-containing vesicles and increased ceramide concentrations within those vesicles and in the cell membranes of Cftrdeficient cells from older mice.
Two previous reports support our notion of defective acidification as a result of diminished Cl -conductance in other cystic fibrosis-affected cell types. These studies demonstrated defective acidification in the Golgi, trans-Golgi network, prelysosomes and endosomes of cystic fibrosis cell lines, leading to abnormal glycosylation of membrane proteins 13 , and showed the same phenomenon in phagolysosomes of alveolar macrophages from Cftr-null mice, leading to impaired bactericidal activity 14 . These results have been questioned 35, 36 . Methodological differences, particularly concerning the thiazolidinone CFTR inhibitor CFTR inh -172, which is very sensitive to storage in stock DMSO solutions at low temperature, may account for some of the discrepant results 14, 36 . Independently of this controversy, it is difficult to compare data employing zymosan conjugates containing fluorescein and tetramethylrhodamine in macrophages or cultured cells 36 with our data employing lysosensor-green on ex vivo epithelial cells.
A decrease in ceramide, rather than an accumulation of ceramide, was observed by other investigators in Cftr-deficient mice fed with the liquid diet Peptamen 29 . Here we show that Peptamen treatment results in a very high cellular concentration of cholesterol that in turn results in reduction of Asm activity and pulmonary ceramide concentrations. Cftr-deficient mice might be particularly sensitive to changes in cholesterol metabolism, as cultured Cftr-deficient cells already show 1.5-fold higher cholesterol levels than normal cells 37 . These levels are too low to alter the activity of Asm; however, as demonstrated in the present study, when Cftr-deficient mice are fed the Peptamen diet, lung cholesterol concentrations increase to such levels that Asm is severely affected. The increase in cholesterol concentration is due to an impressive consumption of the diet by the mice (B75% of body weight in a 24-hour cycle), leading to liver steatosis 38, 39 . It is obvious that such consumption is hard to achieve in humans, with the result being that cholesterol levels will not increase in humans and, hence, Asm levels will not be changed by a diet with Peptamen. Furthermore, any diet that requires a 300-400% increase of cellular cholesterol concentrations to be effective cannot be used in humans, owing to the severely adverse effects of high cholesterol.
According to our data showing a marked shift in ceramide and cholesterol levels after Peptamen, this diet may have also been responsible for the observed essential fatty-acid imbalance in Cftr-deficient mice 40 . This notion is supported by studies showing that hypercholesterolemic subjects or rats significantly increase the cellular level of arachidonic acid 41, 42 .
We identified two mutually non-exclusive pathways that may facilitate bacterial lung infection in cystic fibrosis as a consequence of abnormal ceramide accumulation: the increased release of dead cells into respiratory airways, resulting in the formation of DNA deposits that may serve as bacterial adherence factors, and an increased inflammatory response. The latter may negatively affect lung function and innate immune responses and change the airway architecture to allow enhanced bacterial adhesion and also lung fibrosis.
Whereas the link between ceramide and the induction of cell death has been extensively documented 15, 16, 43 , conflicting results with regard to the rate of apoptosis in Cftr-deficient cells and mice before 44 and after 45 P. aeruginosa infection have been previously described. Here we show that an increased rate of cell death occurs only in the lungs of aged Cftr-deficient mice, which, to our knowledge, has never been shown before. The increase in cell death is most probably caused by accumulated ceramide in cells lacking functional Cftr, as Asm inhibition by amitriptyline or genetic heterozygosity in uninfected Cftr-deficient mice reduced cell death to rates observed in wildtype mice.
The increased rate of cell death causes DNA deposition on the airway epithelium of Cftr-deficient mice. DNA-mucus deposits may facilitate adhesion of P. aeruginosa to abiotic surfaces 46 , an event that is essential for the high susceptibility of Cftr-deficient mice to P. aeruginosa infection. Accumulated ceramide does not seem to promote adhesion per se, as our experiments show that the adhesion of P. aeruginosa strains to washed nasal epithelial cells cultures from people with cystic fibrosis and control individuals does not differ (M.U. and G.D., unpublished data).
Furthermore, it is conceivable that the accumulation of ceramide might severely affect the function of cholera toxin-positive, Triton X-100-insoluble membrane rafts, which were shown to be required for cell activation upon P. aeruginosa lung infections 47 . Curiously, feeding Cftr-deficient mice with Peptamen may also induce hypersusceptibility to infection. Although ceramide selectively displaces cholesterol from ordered lipid rafts 48 , high cholesterol levels may turn this reaction in the other direction, resulting in ceramide-poor, cholesterol-rich rafts. Indeed, a significant improvement in the ability of Cftr-deficient mice to combat P. aeruginosa infection was reported when ceramide levels were normalized by treatment with fenretinide 29 .
Aside from cell death, ceramide is also crucially involved in the regulation of transcription factors 17 , so increased ceramide levels could lead to dysregulation of these factors, subsequently leading to an increase in levels of cytokines and induction of inflammation with age-dependent recruitment of effector cells in uninfected Cftr-deficient mice. How the accumulation of macrophages and neutrophils around submucosal glands contributes to the hypersusceptibility of Cftr-deficient mice to P. aeruginosa lung infection remains to be defined. Both cell types have been implied in tissue remodeling, fibrosis and emphysema mediated by the continuous production of reactive oxygen species, metallo-and serine proteases 49 .
As direct or indirect consequences of the increased ceramide concentrations in cells of the respiratory tract, our data unify several previously published observations in cystic fibrosis mouse model strains with regard to inflammation 9 , apoptosis 44, 45 and hypersusceptibility to P. aeruginosa infection 26, 27 . Furthermore, our findings emphasize that older mice are hypersusceptible to severe pulmonary disease, an observation that is in accordance with previous studies 26 .
In people with cystic fibrosis expressing normal levels of Asm, the described pathophysiological events may provoke a vicious cycle, because P. aeruginosa triggers Asm activation and, hence, ceramide release leading to apoptosis 18 . Thus, the accumulation of ceramide on the respiratory epithelium, caused by the basic defect in cystic fibrosis, may still increase after the onset of chronic P. aeruginosa infection. In such a scenario, the increasing deposition of DNA (as a consequence of increased cell death) would further facilitate bacterial adhesion, impair mucociliary clearance by increasing the viscoelasticity of the airway surface liquid, and augment tissue destruction and remodeling by increasing inflammation. Thus, reduction of ceramide levels by amitriptyline treatment may not only prevent or delay the onset of lung symptoms, but also reduce an existing pulmonary infection in individuals with cystic fibrosis. However, previous studies on mice completely lacking Asm (Smpd1 -/-) showed that these mice are unable to respond with cellular apoptosis and to clear bacteria from airways by internalizing them via epithelial cell ceramide-dependent rafts and subsequently degrading them, and thus fail to control the infection 18 . Thus, any future cystic fibrosis drug targeting the Asm must be carefully titrated to normalize ceramide levels in the lungs of people with cystic fibrosis, but not reduce ceramide concentrations below a critical cellular level that would impair the biological functions of ceramide. In summary, our data identify ceramide as one of the key regulators of inflammation and subsequent infection in cystic fibrosis airways. These findings suggest that normalization of ceramide levels by amitriptyline may represent a new and important strategy to prevent bacterial infections in people with cystic fibrosis.
METHODS
Human subjects. We isolated ciliated epithelial cells from 18 people with cystic fibrosis and 17 healthy control individuals (mean age, 27 ± 7.8 years and 33 ± 6.5 years, respectively), attending the Eberhard-Karls-Universität, Universitätsklinikum, Tübingen, Germany. The study was approved by the Ethics Committee of the University of Tübingen. We obtained samples of normal lungs from three deceased donors (mean age 26 years) in whom the contralateral lung was not used for transplantation, and samples from the explanted lungs from three subjects with cystic fibrosis receiving a double lung transplant from the Department of Pathology, University of Southern California, Los Angeles, in compliance with the University of Southern California Institutional Review Board. We fixed bronchial tissue blocks (B1 cm 3 ) in 10% paraformaldehyde and embedded them in paraffin. All human subjects gave informed consent.
Mice and treatments. For various treatment regimens, infection protocols and lung tissue investigations, we used different Cftr mutant mouse strains and their respective littermates (detailed methods are in Supplementary Methods online). We dissolved amitriptyline in distilled H 2 O and injected it intraperitoneally into mice at a dose of 10 mg/kg twice daily for 2.5 d. We injected Z-VAD (Bachem) intraperitoneally at a dose of 8 mg/kg twice daily for 2.5 d. For Peptamen experiments, we fed mice with Peptamen (Nestlé) ad libitum. A single mouse consumed approximately 17-20 ml of the liquid diet daily, which is in accordance with previous reports 38 . In other experiments, mice inhaled 1 ml of the drugs bafilomycin (1 mM), nigericin (2.5 mM), NH 4 Cl (25 mM), chloroquine (10 mM), N-oleoylethanolamine (100 mM) or DNase (2.5 mg/ml, 25 mg/ml, 100 mg/ml and 1 mg/ml; Roche). We dissolved the drugs in 0.9% NaCl and allowed the mice to inhale them for approximately 20 min. We intranasally infected mice under very short and light ether anesthesia 50 with 1 Â 10 7 or 1 Â 10 8 CFU of P. aeruginosa strains 762, 769 or American Type Culture Collection 14115 or S. pneumoniae strain R6 with a plastic-covered 30-gauge needle, which we inserted 2 mm into the nose. We determined P. aeruginosa cell numbers in mouse lungs 15, 30, 60 or 120 min after challenge. Additionally, we determined the survival of infected mice for 7 d after challenge. To reduce the variation associated with in vivo infectious experiments, we employed a standardized protocol (Supplementary Methods). All procedures performed on mice were approved by the Animal Care and Use Committee of the Bezirksregierung Duesseldorf, Duesseldorf, Germany.
Measurements of enzymes, ceramide, cell death, neutrophils, macrophages and DNA. We measured enzymatic activities of Asm and acid ceramidase and concentrations of ceramide and cholesterol in homogenized lungs from different mouse strains. We homogenized mouse lungs in PBS in a Dounce homogenizer for 30 s. Additionally, we stained human or mouse lung sections for cell death by TUNEL, for ceramide by indirect immunofluorescence and electron microscopy, for neutrophils and macrophages by indirect immunofluorescence and for DNA by DAPI (Roche). Finally, we determined concentrations of the cytokines IL-1 and KC in aliquots of homogenized mouse lungs with commercial ELISAs following the instructions of the manufacturer (R&D), and we determined the adhesions of P. aeruginosa to DNA following procedures outlined in Supplementary Methods.
Isolation of cellular vesicles. We mechanically homogenized mouse lung tissue and incubated it for 30 min at 4 1C in 0.3 M sucrose, 10 mM TES, pH 7.4, and 0.5 mM EGTA (all from Sigma) to swell the cells. We disintegrated cells by 40Â Dounce homogenization, pelleted nuclei and unbroken cells by centrifugation for 5 min at 600g and 4 1C, and permeabilized the vesicles by a 5 min incubation with 0.05% Triton X-100 (Sigma). Then we washed and stained vesicles with antibodies to ceramide (1:100 dilution, Glycobiotech) for 45 min at 4 1C, followed by staining with Cy3-coupled antibodies to mouse IgM and analysis by FACS (all secondary antibodies from Jackson ImmunoResearch).
To investigate the role of the pH in ceramide accumulation, we isolated vesicles as above and incubated intact vesicles in 50 mM PIPES-KOH, 40 mM KCl, 10 mM NaCl, 2 mM MgCl 2 , 2 mM EGTA, 10 mg/ml each aprotinin and leupeptin, 2 mM ATP, 10 mM phosphocreatine, 5 mM succinate, 50 mg/ml creatine kinase and 1% FCS at a pH of 4.5 or 5.9 (all from Sigma, FCS from Gibco-BRL). Then we incubated vesicles at 37 1C for 8 h and analyzed vesicles for ceramide by the diacylglycerol kinase assay (Supplementary Methods). Alternatively, we fixed vesicles for 15 min with 2% paraformaldehyde, permeabilized them with 0.05% Triton X-100, stained them with Cy3-coupled antibodies to ceramide and analyzed them by FACS. The intensity of the staining with Cy3-coupled ceramide-specific antibodies served to measure the amount of ceramide in a single vesicle. pH measurements. We incubated isolated respiratory epithelial cells from Cftrdeficient and wild-type mice with 70 nM lysosensor-green D189 (Molecular Probes) for 15 min and immediately analyzed dye emission by fluorescence microscopy. To isolate intact epithelial cells, we removed the large bronchi and trachea and gently removed cells from the tissue surface. Typically, we analyzed a total of 500 cells (100 epithelial cells from five different mice). To determine the pH, we defined the fluorescence intensity in vesicles in areas of 1.5 Â 1.5 mm. We located samples under minimum light exposure. We captured images with excitation at 488 nm using an argon laser and recorded them at 505 nm emission. We compared the measured fluorescence intensity with a standard curve. To obtain the standard curve, we permeabilized cells and resuspended them in H/S (132 mM NaCl, 20 mM HEPES (pH 7.4), 5 mM KCl, 1 mM CaCl 2 , 0.7 mM MgCl 2 , 0.8 mM MgSO 4 ) with a given pH of 4.5, 4.7, 4.9, 5.1, 5.3, 5.5, 5.7, 5.9, 6.1, 6.3 or 6.5. We incubated cells for 15 min with 70 nM lysosensor-green and determined the fluorescence intensity in an area of 1.5 Â 1.5 mm. The standard curve (random fluorescence units) then served to determine fluorescence intensity and, therefore, the vesicular pH in intact cells. For CFTR inhibitor experiments, we incubated intact cells with 10 mM CFTR inh -172 (Sigma) for 15 min before adding lysosensor-green. The inhibitor was present throughout the whole experiment. Because CFTR inh -172 is very
